11992

524470

SYNCOMF

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SYNCOM FORMU (I) LTD Share Price Today

SYNCOM FORMU (I) LTD is currently trading at ₹14.02, down by ₹0.19 from the previous close. The stock touched an intraday high of ₹14.29 and a low of ₹13.90 during the latest trading session. Over the past one year, SYNCOM FORMU (I) LTD has delivered a loss of 34.69%, while the stock has gained 5.15% in the last one month.

SYNCOM FORMU (I) LTD performance

Today’s low Today’s high
₹ 13.90 ₹ 14.29
₹ 13.99
52 week low 52 week high
₹ 10.21 ₹ 21.25
₹ 13.99
Open Price ₹ 14.22
Prev. Close ₹ 14.22
Volume (Shares) 1885594.00
Total traded value ₹ 263.79
Upper Circuit ₹ 17.06
Lower Circuit ₹ 11.38
info

Investment Returns

Over 1 Month 5.15% Over 3 Months 15.08% Over 6 Months -4.35% Over 1 Year -34.69%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SYNCOM FORMU (I) LTD fundamentals


  • Market cap (Cr) 1,313.20
  • P/E Ratio (TTM) 17.54
  • Beta 1.44
  • Book Value / share 4.38
  • Return on equity 15.60%
  • EPS (TTM) 0.81
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 24.57
info icon alternate text
  • Market cap (Cr) 1,321.60
  • P/E Ratio (TTM) 17.54
  • Beta 1.31
  • Book Value / share 4.38
  • Return on equity 15.60%
  • EPS (TTM) 0.81
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 24.57
info icon alternate text

SYNCOM FORMU (I) LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 134.00
Operating Expense 115.37
Net Profit 24.57
Net Profit Margin (%) 18.33
Earnings Per Share (EPS) 0.26
EBITDA 35.70
Effective Tax Rate (%) 25.22
Particulars DEC 2025 (Values in Cr)
Revenue 114.59
Operating Expense 95.03
Net Profit 18.86
Net Profit Margin (%) 16.45
Earnings Per Share (EPS) 0.20
EBITDA 26.66
Effective Tax Rate (%) 24.67
Particulars SEP 2025 (Values in Cr)
Revenue 121.44
Operating Expense 104.31
Net Profit 16.84
Net Profit Margin (%) 13.86
Earnings Per Share (EPS) 0.18
EBITDA 23.96
Effective Tax Rate (%) 24.68
Particulars JUN 2025 (Values in Cr)
Revenue 116.55
Operating Expense 102.35
Net Profit 15.73
Net Profit Margin (%) 13.49
Earnings Per Share (EPS) 0.21
EBITDA 21.84
Effective Tax Rate (%) 22.35
Particulars MAR 2025 (Values in Cr)
Revenue 148.46
Operating Expense 132.37
Net Profit 17.50
Net Profit Margin (%) 11.78
Earnings Per Share (EPS) 0.19
EBITDA 24.39
Effective Tax Rate (%) 23.94
Particulars MAR 2026 (Values in Cr)
Revenue 486.57
Operating Expense 417.05
Net Profit 76.01
Net Profit Margin (%) 15.62
Earnings Per Share (EPS) 0.81
EBITDA 108.16
Effective Tax Rate (%) 24.39
Particulars MAR 2025 (Values in Cr)
Revenue 462.85
Operating Expense 415.39
Net Profit 48.87
Net Profit Margin (%) 10.55
Earnings Per Share (EPS) 0.52
EBITDA 70.69
Effective Tax Rate (%) 24.42
Particulars MAR 2024 (Values in Cr)
Revenue 258.36
Operating Expense 239.67
Net Profit 23.62
Net Profit Margin (%) 9.14
Earnings Per Share (EPS) 0.32
EBITDA 40.93
Effective Tax Rate (%) 25.62
Particulars MAR 2023 (Values in Cr)
Revenue 224.64
Operating Expense 212.70
Net Profit 20.07
Net Profit Margin (%) 8.93
Earnings Per Share (EPS) 0.20
EBITDA 34.24
Effective Tax Rate (%) 24.46
Particulars MAR 2022 (Values in Cr)
Revenue 219.66
Operating Expense 205.51
Net Profit 19.79
Net Profit Margin (%) 9.00
Earnings Per Share (EPS) 0.26
EBITDA 32.06
Effective Tax Rate (%) 24.40
Particulars MAR 2025 (Values in Cr)
Book Value / Share 3.64
ROE % 15.68
ROCE % 18.54
Total Debt to Total Equity 0.12
EBITDA Margin 15.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.07
ROE % 9.30
ROCE % 10.91
Total Debt to Total Equity 0.29
EBITDA Margin 16.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2.72
ROE % 8.39
ROCE % 9.57
Total Debt to Total Equity 0.29
EBITDA Margin 15.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2.52
ROE % 8.91
ROCE % 9.93
Total Debt to Total Equity 0.26
EBITDA Margin 14.59
Particulars MAR 2017 (Values in Cr)
Book Value / Share 1.50
ROE % 9.32
ROCE % 13.22
Total Debt to Total Equity 0.08
EBITDA Margin 10.46
Particulars MAR 2025 (Values in Cr)
Book Value / Share 3.62
ROE % 15.60
ROCE % 18.44
Total Debt to Total Equity 0.12
EBITDA Margin 15.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.05
ROE % 8.71
ROCE % 10.32
Total Debt to Total Equity 0.29
EBITDA Margin 15.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2.72
ROE % 8.39
ROCE % 9.57
Total Debt to Total Equity 0.29
EBITDA Margin 15.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2.52
ROE % 9.66
ROCE % 10.49
Total Debt to Total Equity 0.29
EBITDA Margin 14.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2.25
ROE % 17.51
ROCE % 20.42
Total Debt to Total Equity 0.19
EBITDA Margin 18.47
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 413.28
Total Liabilities 413.28
Total Equity 342.15
Share Outstanding 94
Price to Book Ratio 4.54
Return on Assets (%) 11.96
Return on Capital (%) 14.26
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 67.86
Total Assets 404.66
Total Liabilities 404.66
Total Equity 288.14
Share Outstanding 94
Price to Book Ratio 3.67
Return on Assets (%) 6.25
Return on Capital (%) 7.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.63
Total Assets 377.83
Total Liabilities 377.83
Total Equity 256.01
Share Outstanding 94
Price to Book Ratio 2.17
Return on Assets (%) 5.31
Return on Capital (%) 5.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 308.23
Total Liabilities 308.23
Total Equity 222.22
Share Outstanding 86
Price to Book Ratio 4.22
Return on Assets (%) 6.42
Return on Capital (%) 7.07
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 6.51
Total Assets 180.17
Total Liabilities 180.17
Total Equity 117.35
Share Outstanding 78
Price to Book Ratio 1.35
Return on Assets (%) 5.84
Return on Capital (%) 8.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 409.68
Total Liabilities 409.68
Total Equity 339.90
Share Outstanding 94
Price to Book Ratio 4.54
Return on Assets (%) 11.92
Return on Capital (%) 14.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 67.83
Total Assets 391.50
Total Liabilities 391.50
Total Equity 286.45
Share Outstanding 94
Price to Book Ratio 3.67
Return on Assets (%) 6.03
Return on Capital (%) 6.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.57
Total Assets 376.94
Total Liabilities 376.94
Total Equity 256.01
Share Outstanding 94
Price to Book Ratio 2.17
Return on Assets (%) 5.32
Return on Capital (%) 5.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 308.23
Total Liabilities 308.23
Total Equity 222.22
Share Outstanding 86
Price to Book Ratio 4.22
Return on Assets (%) 6.42
Return on Capital (%) 7.07
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 64.20
Total Assets 291.64
Total Liabilities 291.64
Total Equity 187.58
Share Outstanding 78
Price to Book Ratio 1.38
Return on Assets (%) 10.00
Return on Capital (%) 11.68
Particulars MAR 2025 (Values in Cr)
Net Income 65.50
Cash from Operations 38.18
Cash from Investing -18.20
Cash from Financing -67.90
Net change in Cash -62.67
Free Cash Flow 48.13
Particulars MAR 2024 (Values in Cr)
Net Income 33.97
Cash from Operations 2.12
Cash from Investing 83.01
Cash from Financing -14.55
Net change in Cash 62.50
Free Cash Flow 10.26
Particulars MAR 2023 (Values in Cr)
Net Income 26.55
Cash from Operations 17.18
Cash from Investing -44.95
Cash from Financing 35.00
Net change in Cash 0.57
Free Cash Flow 37.81
Particulars MAR 2022 (Values in Cr)
Net Income 26.15
Cash from Operations 22.57
Cash from Investing -27.07
Cash from Financing 8.29
Net change in Cash -2.44
Free Cash Flow 33.88
Particulars MAR 2017 (Values in Cr)
Net Income 15.87
Cash from Operations 17.88
Cash from Investing -17.68
Cash from Financing 4.66
Net change in Cash 0.82
Free Cash Flow 30.78
Particulars MAR 2025 (Values in Cr)
Net Income 64.65
Cash from Operations 37.76
Cash from Investing -18.37
Cash from Financing -67.59
Net change in Cash -62.65
Free Cash Flow 47.72
Particulars MAR 2024 (Values in Cr)
Net Income 31.78
Cash from Operations 1.64
Cash from Investing 83.82
Cash from Financing -15.36
Net change in Cash 62.52
Free Cash Flow 9.78
Particulars MAR 2023 (Values in Cr)
Net Income 26.55
Cash from Operations 17.14
Cash from Investing -44.97
Cash from Financing 35.00
Net change in Cash 0.52
Free Cash Flow 37.77
Particulars MAR 2022 (Values in Cr)
Net Income 26.15
Cash from Operations 22.57
Cash from Investing -27.07
Cash from Financing 8.29
Net change in Cash -2.44
Free Cash Flow 33.88
Particulars MAR 2021 (Values in Cr)
Net Income 40.67
Cash from Operations 9.23
Cash from Investing -75.35
Cash from Financing 71.96
Net change in Cash -5.45
Free Cash Flow 11.89
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD. 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD. 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.80 14.94 2.45 997.12 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTAJAN HEALTH LTD 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA IND LT 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 438.10 47.26 4.02 4646.32 118.35 462.70

SYNCOM FORMU (I) LTD shareholding pattern

Holding
49.21%
50.56%
0.21%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SYNCOM FORMU (I) LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
13.97 -1.75 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 14.30
  • 26 Days 14.30
  • 10 Days 14.40
  • 50 Days 14.10
  • 12 Days 14.40
  • 100 Days 14.00
  • 20 Days 14.40
  • 200 Days 14.70
13.93 PIVOT
First Support 13.72 First Resistance 14.11 Second Support 13.54 Second Resistance 14.32 Third Support 13.33 Third Resistance 14.50
RSI 49.21 ADX 12.70 MACD 0.07 Williams % R -81.21 Commodity Channel Index (CCI) -52.99
Date 2026-06-12 Week 798792.00 Same Day 829382.00 Month 1209241.00
1 Year 1.45 3 Year 1.19
Over 1 Month
5.15% down
Over 1 Year
-34.69% down
Over 3 Months
15.08% down
Over 3 Years
22.83% down
Over 6 Months
-4.35% down
Over 5 Years
0.00% down

SYNCOM FORMU (I) LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
09 Sep 2022 0.03 Final 13 Sep 2022 Equity shares
21 Sep 2017 0.02 Final 23 Sep 2017 Equity shares
22 Sep 2016 0.02 Final 26 Sep 2016 Equity shares
16 Sep 2015 0.02 Final 19 Sep 2015 Equity shares
18 Sep 2014 0.02 Final 20 Sep 2014 Equity shares
10 Jul 2013 0.6 Final 12 Jul 2013 Equity shares
20 Sep 2012 0.6 Final 24 Sep 2012 Equity shares
22 Sep 2011 0.5 Final 26 Sep 2011 Equity shares
23 Sep 2010 0.5 Final 27 Sep 2010 Equity shares
24 Sep 2009 0.5 Final 28 Sep 2009 Equity shares
23 Sep 2008 0.5 Final 25 Sep 2008 Equity shares
20 Sep 2007 1.0 Final 24 Sep 2007 Equity shares
19 Sep 2006 0.0 Final 21 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 26 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
20 Aug 2013 19 Aug 2013 5:2
Ex-Date Old FV NEW FV Record Date
19 Aug 2013 10.0 1.0 20 Aug 2013
Dividend date Dividend amount Dividend type Record date Instrument type
09 Sep 2022 0.03 Final 13 Sep 2022 Equity shares
21 Sep 2017 0.02 Final 23 Sep 2017 Equity shares
22 Sep 2016 0.02 Final 26 Sep 2016 Equity shares
16 Sep 2015 0.02 Final 19 Sep 2015 Equity shares
18 Sep 2014 0.02 Final 20 Sep 2014 Equity shares
10 Jul 2013 0.6 Final 12 Jul 2013 Equity shares
20 Sep 2012 0.6 Final 24 Sep 2012 Equity shares
22 Sep 2011 0.5 Final 26 Sep 2011 Equity shares
23 Sep 2010 0.5 Final 27 Sep 2010 Equity shares
24 Sep 2009 0.5 Final 28 Sep 2009 Equity shares
23 Sep 2008 0.5 Final 25 Sep 2008 Equity shares
20 Sep 2007 1.0 Final 24 Sep 2007 Equity shares
19 Sep 2006 0.0 Final 21 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 26 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
20 Aug 2013 19 Aug 2013 5:2
Ex-Date Old FV NEW FV Record Date
19 Aug 2013 10.0 1.0 20 Aug 2013

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Syncom Formulations (India) Ltd?

Answer Field

Syncom Formulations (India) Ltd share price is for NSE ₹ 14.02 & for BSE ₹ 14.00 as on Jun 18 2026 03:29 PM.

What is the Market Cap of Syncom Formulations (India) Ltd Share?

Answer Field

The market cap of Syncom Formulations (India) Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 18 2026 03:29 PM.

What is the 52 Week High and Low of Syncom Formulations (India) Ltd?

Answer Field

The 52 Week High and Low of Syncom Formulations (India) Ltd for NSE is ₹ 21.25 and ₹ 10.21 and for BSE is ₹ 21.80 and ₹ 10.21.

What is 1 year return for Syncom Formulations (India) Ltd?

Answer Field

The 1 year returns on the stock has been -29.84%.

What is the P/E Ratio of Syncom Formulations (India) Ltd Share?

Answer Field

As on Jun 18 2026 03:29 PM the price-to-earnings (PE) ratio for Syncom Formulations (India) Ltd share is 17.54.

What is the PB ratio of Syncom Formulations (India) Ltd Share?

Answer Field

As on Jun 18 2026 03:29 PM, the price-to-book (PB) ratio for Syncom Formulations (India) Ltd share is 4.38.

How to Buy Syncom Formulations (India) Ltd Share?

Answer Field

You can trade in Syncom Formulations (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Syncom Formulations (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Syncom Formulations (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Syncom Formulations (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|